WallStreetZenWallStreetZen

NASDAQ: REVB
Revelation Biosciences Inc Stock Ownership - Who owns Revelation Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Revelation Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jennifer CarverDirector2025-02-11181$3.87
$700.47Buy
Lakhmir S. ChawlaDirector2025-02-11181$3.87
$700.47Buy
James RolkeChief Executive Officer2025-02-1130,095$3.87
$116.47kBuy
Jess RoperDirector2025-02-11181$3.87
$700.47Buy
George F. TidmarshDirector2025-02-11181$3.87
$700.47Buy
Chester Stanley Zygmont IiiChief Financial Officer2025-02-1115,048$3.87
$58.24kBuy

1 of 1

REVB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REVB insiders and whales buy or sell their stock.

REVB Shareholders

What type of owners hold Revelation Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Axa IM Prime Impact Master Fund I Sca Sicavraif609.77%1,958,984$5.27MInsider
Andreas Typaldos550.80%1,769,538$4.76MInsider
Sean H. Fitzpatrick550.80%1,769,538$4.76MInsider
George F. Tidmarsh474.19%1,523,422$4.10MInsider
Lawrence Feis232.36%746,491$2.01MInsider
Glazer Capital LLC118.63%381,106$1.03MInsider
Robert D. Nicholson3.11%10,000$26.90kInsider
David Dobkin3.11%10,000$26.90kInsider
William Howard Carson3.11%10,000$26.90kInsider
Anthony Hayes3.11%10,000$26.90kInsider

1 of 3

REVB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REVB0.10%99.90%Net Buying
OGEN0.68%99.32%Net SellingNet Selling
APVO0.55%99.45%
NCNA0.18%0.00%
CDT0.82%99.18%Net SellingNet Buying
View Top Biotech Stocks

Revelation Biosciences Stock Ownership FAQ

Who owns Revelation Biosciences?

Revelation Biosciences (NASDAQ: REVB) is owned by 2.66% institutional shareholders, 2,556.66% Revelation Biosciences insiders, and 0.00% retail investors. Axa IM Prime Impact Master Fund I Sca Sicavraif is the largest individual Revelation Biosciences shareholder, owning 1.96M shares representing 609.77% of the company. Axa IM Prime Impact Master Fund I Sca Sicavraif's Revelation Biosciences shares are currently valued at $4.65M.

If you're new to stock investing, here's how to buy Revelation Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.